Myanmar documents

Annual progress reports

Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.

Annual progress report Myanmar 2007

Annual progress report Myanmar 2014

Annual progress report Myanmar 2006

Annual progress report Myanmar 2013

Annual progress report Myanmar 2004

Annual progress report Myanmar 2012

Annual progress report Myanmar 2005

Annual progress report Myanmar 2011

Annual progress report Myanmar 2003

Annual progress report Myanmar 2010

Annual progress report Myanmar 2002

Annual progress report Myanmar 2009

Annual progress report Myanmar 2001

Annual progress report Myanmar 2008

The joint appraisal report and Multi-Stakeholder Dialogue

The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.

In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.

Joint Appraisal Myanmar 2019

Joint Appraisal Myanmar 2017

Joint Appraisal Myanmar 2018

Joint Appraisal Myanmar 2016

Joint Appraisal Myanmar 2015

Joint Appraisal Myanmar 2014

Approved proposals

All eligible countries are invited to submit proposals for Gavi support. 

Proposal for TCA support 2022:Myanmar

Date of Gavi approval:

Proposal for NVS - HPV vaccine (2020-2021): Myanmar

Date of Gavi approval:

Proposal for NVS - MR follow-up and rota support 2019 - Myanmar

Date of Gavi approval:

Proposal for CCEOP support 2017: Myanmar

Date of Gavi approval:

Proposal for NVS - JE support: Myanmar

Date of Gavi approval:

Proposal for HSS support 2016: Myanmar

Date of Gavi approval:

Proposal for Pneumo Support 2015: Myanmar

Date of Gavi approval:

Proposal for NVS - IPV support: Myanmar

Date of Gavi approval:

Proposal for MR support: Myanmar

Date of Gavi approval:

Proposal for NVS - Penta support: Myanmar

Date of Gavi approval:

Proposal for NVS - MSD support: Myanmar

Date of Gavi approval:

Proposal for ISS support: Myanmar

Date of Gavi approval:

Proposal for HSS support: Myanmar

Date of Gavi approval:

Proposal for ISS, INS support: Myanmar

Date of Gavi approval:

Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy

The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives. 

Comprehensive Multi-Year Plan Myanmar 2017-2021

Comprehensive multi-year plan for 2007-2011

Country co-financing information sheet

The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.

Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.

The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).

Co-financing information sheet Myanmar

Decision Letters and Partnerships Agreement

The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.

Decision Letter PENTA Myanmar 2023

Decision Letter RV Myanmar 2023

Decision Letter JEV Myanmar 2023

Decision Letter IPV Myanmar 2023

Decision Letter HPV Myanmar 2022

Decision Letter IPV Myanmar 2022

Decision Letter JEV Myanmar 2022

Decision Letter PCV Myanmar 2022

Decision Letter PENTA Myanmar 2022

Decision Letter RV Myanmar 2022

Decision Letter IPV Myanmar 2021

Decision Letter PCV Myanmar 2020

Decision Letter JEV Myanmar 2020

Decision Letter PENTA Myanmar 2020

Decision Letter IPV Myanmar 2020

Decision Letter HSS Myanmar 2020

Decision Letter ISD Myanmar 2019

Decision Letter PENTA Myanmar 2019

Decision Letter PCV Myanmar 2019

Decision Letter JEV Myanmar 2019

Decision Letter IPV Myanmar 2019

Decision Letter NVS Myanmar 2017 (5)

Decision Letter NVS Myanmar 2016 (2)

Decision Letter NVS Myanmar 2014(2)

Decision Letter Myanmar MR 2019

Decision Letter CCEOP Myanmar 2017

Decision Letter NVS Myanmar 2016 (3)

Decision Letter NVS Myanmar 2014(3)

Decision Letter ISD Myanmar 2019

Decision Letter NVS Myanmar 2017 (2)

Decision Letter NVS Myanmar 2016 (4)

Decision Letter NVS Myanmar 2014

Decision Letter NVS Myanmar 2019

Decision Letter NVS Myanmar 2017

Decision Letter NVS Myanmar 2016

Decision letter NVS and HSS Myanmar 2013

Decision Letter HSS Myanmar 2018

Decision Letter Devices Myanmar 2017

Decision Letter NVS Myanmar 2015 (3)

Decision Letter Devices Myanmar 2017 (2)

Decision Letter Devices Myanmar 2016 (2)

Decision Letter NVS Myanmar 2015 (2)

Decision Letter NVS Myanmar 2017 (3)

Decision Letter NVS Myanmar 2016 (5)

Decision Letter NVS Myanmar 2015

Decision Letter NVS Myanmar 2017 (4)

Decision Letter Devices Myanmar 2016

Decision Letter HSS Myanmar 2014

Decision Letter HSS Myanmar 2019

COVAX Technical Assistance Plans

In September 2020, the Gavi Board approved resources from core funding to focus on urgent technical assistance (TA) needs for 92 AMC economies, for the planning and preparation for the introduction of the COVID-19 vaccine. The plan includes sets of activities, milestones and budget for a given year.

COVAX Technical Assistance Plan Myanmar 2021

Targeted country assistance plans

Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.

Targeted Country Assistance Plan Myanmar 2022

Targeted Country Assistance Plan Myanmar 2021

Targeted Country Assistance Plan Myanmar 2020

Targeted Country Assistance Plan Myanmar 2019

Targeted country assistance plan Myanmar 2018

Targeted country assistance plan Myanmar 2017

Subscribe to our newsletter